Ohio State doctors and researchers are studying ovarian cancer at a molecular level to bring innovative treatments to patients. Approximately 22,000 women are diagnosed with ovarian cancer in the U.S. each year, while around 14,000 lose their lives, making it the leading cause of gynecological cancer deaths in the country. To better treat ovarian cancer, experts at the OSUCCC – James are conducting genetic and molecular research to help develop innovative therapies for patients. “The progress of ovarian cancer treatment has been fairly amazing,” David O’Malley, MD, says. “What we're doing is we're taking those cancers and looking at the molecular makeup, and then creating a personalized approach.”